Aim and Scope Paediatric Drugs promotes the optimisation and advancement of all aspects of pharmaceutical care in children with a programme of review articles providing healthcare decision makers with clinically applicable knowledge on issues relevant to drug therapy in all areas of neonatology, paediatrics and the care of adolescents. Definitive reviews of topics relating to the effective and safe management of drug therapy in children through all stages of development Disease management reviews covering optimum drug management of specific disorders of fetal development, the neonatal period, childhood and adolescence Adis Drug Evaluations reviewing the properties and place in therapy of both newer and established drugs in children Adis New Drug Profiles with expert commentary. Original research articles will also be considered for publication.
All manuscripts are subject to peer review by international experts.
Letters to the Editor are welcomed and will be considered for publication. A free sample issue of this journal is available either online or a free print copy may be requested . In addition to an Editorial Board comprising internationally acknowledged experts in their fields, the Journal has an extensive peer-review panel, ensuring that all manuscripts meet the high standards expected of Paediatric Drugs . An acknowledgement of this panel can be found in the December issue of the Journal. Instructions for Authors Articles in Paediatric Drugs are either commissioned from leading international experts, or are written by Adis' own staff of experienced scientific editors.